Managing myasthenia gravis (MG) in patients who lack acetylcholine receptor (AChR) autoantibodies can be challenging, particularly as treatment considerations and the available evidence vary across muscle-specific kinase (MuSK), lipoprotein receptor-related protein 4 (LRP4), and triple-seronegative MG. As these distinct patient populations are better characterized and treatment options continue to evolve, clinicians must navigate an increasingly complex landscape to individualize care.Join two leading MG experts as they explore the evolving treatment landscape for MG beyond AChR. Explore the benefits and limitations of conventional and neonatal Fc receptor (FcRn)-targeted therapies, evaluate efficacy and safety data for FcRn inhibition across MuSK, LRP4, and triple-seronegative MG, and consider practical strategies for translating the evidence into individualized treatment decisions. Gain insights into balancing disease progression, treatment burden, and patient-centered goals to optimize management for patients with non-AChR MG.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedSep 30, 2026
-
Last day to claim creditSep 30, 2027 12 months left
-
PRIME Education, Inc. (PRIME®) Myasthenia Gravis Beyond the Acetylcholine Receptor: Mechanisms, Phenotypes, and Diagnostic Essentials
-
PRIME Education, Inc. (PRIME®) Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice
-
PRIME Education, Inc. (PRIME®) Bringing Ocular Myasthenia Gravis Into Focus: From Diagnostic Dilemmas to Targeted Therapeutics
